Literature DB >> 17446798

Relationship between phytosterol levels and components of the metabolic syndrome in the PROCAM study.

Gerd Assmann1, Paul Cullen, Frank Kannenberg, Helmut Schulte.   

Abstract

BACKGROUND: Components of the metabolic syndrome such as hypertriglyceridemia, low high-density lipoprotein (HDL) cholesterol and obesity have been shown to be associated with increased cholesterol synthesis and reduced cholesterol absorption. In the present study, we measured the lathosterol/cholesterol ratio as an index of cholesterol synthesis and the ratios of cholestanol, campesterol and sitosterol to cholesterol as indices of cholesterol absorption, as well as components of the metabolic syndrome, in 324 men and 168 women from the PROCAM study, an epidemiological study in which raised sitosterol was previously associated with increased coronary risk. Our aim was to determine if the indices of cholesterol synthesis and absorption show a graded relationship with severity of metabolic syndrome.
RESULTS: No differences were seen between men and women with regard to the relationship of either the lathosterol/cholesterol or the sitosterol/cholesterol ratios and severity of metabolic syndrome. On multiple regression analysis in men and women together, body mass index showed a positive relationship with the lathosterol/cholesterol ratio (r=0.257, P<0.001) and a negative relationship with the sitosterol/cholesterol ratio (r=-0.221, P<0.001). HDL-cholesterol showed a negative relationship with the lathosterol/cholesterol ratio (r=-0.166, P=0.001). Triglycerides showed a negative relationship with the sitosterol/cholesterol ratio (r=0.141, P=0.005). Overall, these relationships were graded across quintiles of HDL cholesterol, body mass index and triglyceride and across an index of metabolic syndrome severity (number of components present). Only the cholestanol/cholesterol ratio showed a graded relationship with estimated overall coronary risk.
CONCLUSIONS: The metabolic syndrome is associated with increased cholesterol synthesis and reduced cholesterol absorption in a relationship that is graded across severity of the individual components of the syndrome and across an index of the severity of the metabolic syndrome as a whole.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17446798     DOI: 10.1097/HJR.0b013e3280148201

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  5 in total

Review 1.  Will Lipidation of ApoA1 through Interaction with ABCA1 at the Intestinal Level Affect the Protective Functions of HDL?

Authors:  Eric J Niesor
Journal:  Biology (Basel)       Date:  2015-01-06

Review 2.  A Newly Integrated Model for Intestinal Cholesterol Absorption and Efflux Reappraises How Plant Sterol Intake Reduces Circulating Cholesterol Levels.

Authors:  Takanari Nakano; Ikuo Inoue; Takayuki Murakoshi
Journal:  Nutrients       Date:  2019-02-01       Impact factor: 5.717

3.  The Plasma Distribution of Non-cholesterol Sterol Precursors and Products of Cholesterol Synthesis and Phytosterols Depend on HDL Concentration.

Authors:  Valéria Sutti Nunes; Eliton Juniro da Silva; Guilherme da Silva Ferreira; Sayonara Ivana Santos de Assis; Patrícia Miralda Cazita; Edna Regina Nakandakare; Vanessa Helena de Souza Zago; Eliana Cotta de Faria; Eder Carlos Rocha Quintão
Journal:  Front Nutr       Date:  2022-03-01

4.  Sex-specific differences in the predictive value of cholesterol homeostasis markers and 10-year cardiovascular disease event rate in Framingham Offspring Study participants.

Authors:  Nirupa R Matthan; Lei Zhu; Michael Pencina; Ralph B D'Agostino; Ernst J Schaefer; Alice H Lichtenstein
Journal:  J Am Heart Assoc       Date:  2013-02-19       Impact factor: 5.501

5.  Metabolism of plasma cholesterol and lipoprotein parameters are related to a higher degree of insulin sensitivity in high HDL-C healthy normal weight subjects.

Authors:  Camila C Leança; Valéria S Nunes; Natália B Panzoldo; Vanessa S Zago; Eliane S Parra; Patrícia M Cazita; Matti Jauhiainen; Marisa Passarelli; Edna R Nakandakare; Eliana C de Faria; Eder C R Quintão
Journal:  Cardiovasc Diabetol       Date:  2013-11-22       Impact factor: 9.951

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.